Quantifying Digital Behavior on Smart Phones - Data From Stroke Survivors
Launched by UNIVERSITY OF AARHUS · May 26, 2020
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how stroke survivors use their smartphones in the first three months after leaving the hospital. Researchers want to understand how smartphone interactions might relate to the participants’ daily activities and overall well-being. By tracking the smartphone usage of 50 stroke survivors, they aim to see if there are any connections between how people use their phones and their recovery progress.
To participate in this study, individuals must be between 18 and 99 years old, have experienced a new or recurring stroke, and be discharged home after rehabilitation. They should also own an Android smartphone that they use themselves. Unfortunately, people with serious memory issues or mental health conditions that could affect their ability to participate will not be eligible. If you join the study, you can expect to share information about your smartphone usage at various points during the trial, helping researchers learn more about the recovery process for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • New or recurrent stroke, admitted to rehabilitation, discharge to own home
- • Owns an Android smart phone
- • Smart phone is used by the patient only
- Exclusion Criteria:
- • Severe cognitive impairments and / or psychiatric and behavioral conditions that interfere with compliance.
- • Not able to provide informed consent
- • Discharge to nursing homes or other care facilities
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hammel, Aarhus, Denmark
Patients applied
Trial Officials
Iris C. Brunner, PhD
Principal Investigator
Aarhus University, Hammel Neurocenter
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials